Evidence map›Paper›PMID 20047189›Full record

ArticleBiotechnology and bioengineering2010

High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system.

Zhong Huang, Waranyoo Phoolcharoen, Huafang Lai, Khanrat Piensook, Guy Cardineau, Larry Zeitlin, Kevin J Whaley, Charles J Arntzen, Hugh S Mason, Qiang Chen

Open access · greenAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 191 citations in OpenAlex.

  1. Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. High-Level Production of a Recombinant Protein inInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zhong HuangThe Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, Arizona 85287-4501, USA.
Waranyoo Phoolcharoen
Huafang Lai
Khanrat Piensook
Guy Cardineau
Larry Zeitlin
Kevin J Whaley
Charles J Arntzen
Hugh S Mason
Qiang Chen
Arizona State University · US

Funding

Monoclonal Antibodies in Biodefense: Ebola VirusesU01AI061270 · NIAID · MAPP BIOPHARMACEUTICAL, INC. · PI ZEITLIN, LARRY · 2005 to 2009
$6.1M
Plant-derived vaccines against hepatitis C Cooperative *U19AI066332 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI ARNTZEN, CHARLES JOEL · 2005 to 2009
$3.6M
Development of a vaccine for Ebola virus in plant systemU01AI061253 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI ARNTZEN, CHARLES JOEL · 2005 to 2008
$2.9M
Plant-derived MAb therapeutics for west nile virusU01AI075549 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI CHEN, QIANG · 2007 to 2010
$1.6M
NIAID NIH HHS 1U01AI075549NIAID NIH HHS 5U01AI061253NIAID NIH HHS 5U01AI061270NIAID NIH HHS U01 AI061253NIAID NIH HHS U01 AI061270NIAID NIH HHS U01AI061270NIAID NIH HHS U01 AI075549NIAID NIH HHS U19 AI066332
6 · The paper itself

Abstract

Plant viral vectors have great potential in rapid production of important pharmaceutical proteins. However, high-yield production of hetero-oligomeric proteins that require the expression and assembly of two or more protein subunits often suffers problems due to the "competing" nature of viral vectors derived from the same virus. Previously we reported that a bean yellow dwarf virus (BeYDV)-derived, three-component DNA replicon system allows rapid production of single recombinant proteins in plants (Huang et al., 2009. Biotechnol Bioeng 103: 706-714). In this article, we report further development of this expression system for its application in high-yield production of oligomeric protein complexes including monoclonal antibodies (mAbs) in plants. We showed that the BeYDV replicon system permits simultaneous efficient replication of two DNA replicons and thus, high-level accumulation of two recombinant proteins in the same plant cell. We also demonstrated that a single vector that contains multiple replicon cassettes was as efficient as the three-component system in driving the expression of two distinct proteins. Using either the non-competing, three-vector system or the multi-replicon single vector, we produced both the heavy and light chain subunits of a protective IgG mAb 6D8 against Ebola virus GP1 (Wilson et al., 2000. Science 287: 1664-1666) at 0.5 mg of mAb per gram leaf fresh weight within 4 days post-infiltration of Nicotiana benthamiana leaves. We further demonstrated that full-size tetrameric IgG complex containing two heavy and two light chains was efficiently assembled and readily purified, and retained its functionality in specific binding to inactivated Ebola virus. Thus, our single-vector replicon system provides high-yield production capacity for hetero-oligomeric proteins, yet eliminates the difficult task of identifying non-competing virus and the need for co-infection of multiple expression modules. The multi-replicon vector represents a significant advance in transient expression technology for antibody production in plants.

Indexed as

Gene ExpressionGenetic VectorsAntibodies, MonoclonalAntibodies, ViralBiotechnologyGeminiviridaeImmunoglobulin GNicotianaProtein MultimerizationViral Envelope ProteinsAntibodies, MonoclonalAntibodies, Viralenvelope glycoprotein, Ebola virusImmunoglobulin GViral Envelope Proteins

Identifiers

PMID20047189
PMCPMC2905544
OpenAlexW2131304438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.